Finn Olav Levy

5.4k total citations
131 papers, 4.1k citations indexed

About

Finn Olav Levy is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cellular and Molecular Neuroscience. According to data from OpenAlex, Finn Olav Levy has authored 131 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 98 papers in Molecular Biology, 43 papers in Cardiology and Cardiovascular Medicine and 30 papers in Cellular and Molecular Neuroscience. Recurrent topics in Finn Olav Levy's work include Receptor Mechanisms and Signaling (57 papers), Cardiac electrophysiology and arrhythmias (24 papers) and Phosphodiesterase function and regulation (22 papers). Finn Olav Levy is often cited by papers focused on Receptor Mechanisms and Signaling (57 papers), Cardiac electrophysiology and arrhythmias (24 papers) and Phosphodiesterase function and regulation (22 papers). Finn Olav Levy collaborates with scholars based in Norway, United States and United Kingdom. Finn Olav Levy's co-authors include Alberto J. Kaumann, Kurt A. Krobert, Kjetil Wessel Andressen, Vidar Hansson, Kjetil Taskén, Trond Brattelid, Lutz Birnbaumer, Eirik Qvigstad, Tore Jahnsen and Knut Martin Torgersen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Finn Olav Levy

129 papers receiving 4.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Finn Olav Levy Norway 36 2.5k 1.1k 794 382 363 131 4.1k
Antônio Felipe Spain 39 2.8k 1.1× 700 0.6× 1.2k 1.5× 479 1.3× 279 0.8× 157 4.3k
Richard Z. Lin United States 36 2.3k 0.9× 547 0.5× 726 0.9× 384 1.0× 292 0.8× 81 3.9k
Anthony L. Albiston Australia 33 2.0k 0.8× 1.1k 1.0× 1.4k 1.8× 312 0.8× 213 0.6× 72 4.4k
Rennolds S. Ostrom United States 33 2.6k 1.0× 725 0.6× 394 0.5× 620 1.6× 233 0.6× 75 4.2k
Hisao Yamamura Japan 33 2.3k 1.0× 658 0.6× 684 0.9× 499 1.3× 317 0.9× 148 3.9k
Sébastien Roger France 42 2.3k 0.9× 559 0.5× 302 0.4× 289 0.8× 248 0.7× 91 4.2k
Canan G. Nebigil France 31 1.7k 0.7× 623 0.6× 743 0.9× 408 1.1× 140 0.4× 67 3.2k
Tsutomu Nakahara Japan 31 2.0k 0.8× 459 0.4× 384 0.5× 602 1.6× 192 0.5× 234 4.3k
Yoshiyuki Horio Japan 46 4.5k 1.8× 1.5k 1.3× 950 1.2× 1.4k 3.8× 492 1.4× 121 7.5k

Countries citing papers authored by Finn Olav Levy

Since Specialization
Citations

This map shows the geographic impact of Finn Olav Levy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Finn Olav Levy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Finn Olav Levy more than expected).

Fields of papers citing papers by Finn Olav Levy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Finn Olav Levy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Finn Olav Levy. The network helps show where Finn Olav Levy may publish in the future.

Co-authorship network of co-authors of Finn Olav Levy

This figure shows the co-authorship network connecting the top 25 collaborators of Finn Olav Levy. A scholar is included among the top collaborators of Finn Olav Levy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Finn Olav Levy. Finn Olav Levy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Levy, Finn Olav & Jan‐Bjørn Osnes. (2023). Can acetate via FFA receptors contribute to the diabetogenic effect of statins?. Naunyn-Schmiedeberg s Archives of Pharmacology. 397(2). 1245–1248. 1 indexed citations
2.
Robinson, Jerid W., Deborah M. Dickey, Adrian J. Hobbs, et al.. (2023). Novel enhancers of guanylyl cyclase‐A activity acting via allosteric modulation. British Journal of Pharmacology. 180(24). 3254–3270. 2 indexed citations
3.
Moltzau, Lise Román, et al.. (2022). Phosphodiesterases and Compartmentation of cAMP and cGMP Signaling in Regulation of Cardiac Contractility in Normal and Failing Hearts. International Journal of Molecular Sciences. 23(4). 2145–2145. 31 indexed citations
4.
Manfra, Ornella, Alexander Froese, Nicoletta C. Surdo, et al.. (2021). CNP regulates cardiac contractility and increases cGMP near both SERCA and TnI: difference from BNP visualized by targeted cGMP biosensors. Cardiovascular Research. 118(6). 1506–1519. 15 indexed citations
5.
Lai, N. Chin, H. Kirk Hammond, Jan‐Bjørn Osnes, et al.. (2019). Constitutive inhibitory G protein activity upon adenylyl cyclase-dependent cardiac contractility is limited to adenylyl cyclase type 6. PLoS ONE. 14(6). e0218110–e0218110. 4 indexed citations
6.
Olberg, Dag Erlend, Kjetil Wessel Andressen, Trine Hjørnevik, et al.. (2016). Brain penetrant small molecule 18F-GnRH receptor (GnRH-R) antagonists: Synthesis and preliminary positron emission tomography imaging in rats. Nuclear Medicine and Biology. 43(8). 478–489. 6 indexed citations
7.
Brattelid, Trond & Finn Olav Levy. (2011). Quantification of GPCR mRNA Using Real-Time RT-PCR. Methods in molecular biology. 746. 165–193. 7 indexed citations
8.
Moltzau, Lise Román, et al.. (2010). Synthesis and pharmacological properties of novel hydrophilic 5-HT4 receptor antagonists. Bioorganic & Medicinal Chemistry. 18(24). 8600–8613. 15 indexed citations
9.
Kjekshus, John, Christian Torp‐Pedersen, Lars Gullestad, et al.. (2009). Effect of Piboserod, a 5-HT4 Serotonin Receptor Antagonist, on Left Ventricular Function in Patients with Symptomatic Heart Failure. European Journal of Heart Failure. 11(8). 771–778. 19 indexed citations
10.
Qvigstad, Eirik, Lise Román Moltzau, Jan Magnus Aronsen, et al.. (2009). Natriuretic peptides increase β1-adrenoceptor signalling in failing hearts through phosphodiesterase 3 inhibition. Cardiovascular Research. 85(4). 763–772. 48 indexed citations
11.
Skomedal, Tor, et al.. (2008). Calculating reaction rate constants and estimating the efficacy of selective enzyme inhibitors. Analytical Biochemistry. 383(2). 323–325. 3 indexed citations
12.
Ramberg, Håkon, Turid Eide, Kurt A. Krobert, et al.. (2008). Hormonal regulation of β2‐adrenergic receptor level in prostate cancer. The Prostate. 68(10). 1133–1142. 35 indexed citations
13.
Schulte, Gunnar & Finn Olav Levy. (2007). Novel aspects of G‐protein‐coupled receptor signalling – different ways to achieve specificity. Acta Physiologica. 190(1). 33–38. 19 indexed citations
14.
Birkeland, Jon Arne Kro, Fredrik Swift, Ulla Enger, et al.. (2007). Serotonin increases L-type Ca2+ current and SR Ca2+ content through 5-HT4 receptors in failing rat ventricular cardiomyocytes. American Journal of Physiology-Heart and Circulatory Physiology. 293(4). H2367–H2376. 21 indexed citations
15.
Qvigstad, Eirik, Trond Brattelid, Ivar Sjaastad, et al.. (2005). Rationale for treatment of heart failure by blockade of ventricular serotonin receptors appearing in heart failure. Queensland's institutional digital repository (The University of Queensland). 1 indexed citations
16.
Andressen, Kjetil Wessel, Jens Henrik Norum, Finn Olav Levy, & Kurt A. Krobert. (2005). Activation of Adenylyl Cyclase by Endogenous Gs-Coupled Receptors in Human Embryonic Kidney 293 Cells Is Attenuated by 5-HT7 Receptor Expression. Molecular Pharmacology. 69(1). 207–215. 36 indexed citations
17.
Taskén, Kjetil, Rigmor Solberg, Helle Katrine Knutsen, et al.. (1997). 16 Structure, function, and regulation of human cAMP-dependent protein kinases. 191–204. 139 indexed citations
18.
Hořejšı́, Václav, Finn Olav Levy, Erlend B. Smeland, et al.. (1997). CDw78 — a determinant on a major histocompatibility complex class II subpopulation that can be induced to associate with the cytoskeleton. European Journal of Immunology. 27(12). 3206–3213. 11 indexed citations
19.
Levy, Finn Olav, Anne Hansen Ree, Lars Eikvar, et al.. (1989). Glucocorticoid Receptors and Glucocorticoid Effects in Rat Sertoli Cells*. Endocrinology. 124(1). 430–436. 64 indexed citations
20.
Levy, Finn Olav, Lars Eikvar, N. H. P. M. Jutte, & Vidar Hansson. (1984). Properties and Compartmentalization of the Testicular Receptor for 1,25‐Dihydroxyvitamin D3a. Annals of the New York Academy of Sciences. 438(1). 591–593. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026